The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice

The role of the dynorphin/κ opioid receptor system in anxiety

(2015) Ai Hang et al.   ACTA PHARMACOLOGICA SINICA

Antagonism of κ opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence

(2015) Gui-Ying Zan et al.   BEHAVIOURAL BRAIN RESEARCH

Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice

(2015) Nastaran Kordjazy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Evaluation of anxiolytic activity of the essential oil of the aerial part of Foeniculum vulgare Miller in mice

(2014) Miraf Mesfin et al.   BMC Complementary and Alternative Medicine

Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models

(2014) Deepali Gupta et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with κ agonist and μ agonist/antagonist activity

(2014) Jian-Feng Sun et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Anti-anxiety effect of a novel 5-HT3receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice

(2014) YeshwantVijay Kurhe et al.   INDIAN JOURNAL OF PHARMACOLOGY

Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults

(2014) Jordan F. Karp et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice

(2014) Edgardo Falcon et al.   PSYCHOPHARMACOLOGY

Individual differences in elevated plus-maze exploration predicted higher ethanol consumption and preference in outbred mice

(2013) Amine Bahi   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Role of kappa-opioid receptors in stress and anxiety-related behavior

(2013) Ashlee Van’t Veer et al.   PSYCHOPHARMACOLOGY

Active behaviours produced by antidepressants and opioids in the mouse tail suspension test

(2012) Esther Berrocoso et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Stress-Induced Activation of the Dynorphin/ -Opioid Receptor System in the Amygdala Potentiates Nicotine Conditioned Place Preference

(2012) J. S. Smith et al.   JOURNAL OF NEUROSCIENCE

Kappa opioid regulation of anxiety-like behavior during acute ethanol withdrawal

(2012) Glenn R. Valdez et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Effects of a Post-Shock Injection of the Kappa Opioid Receptor Antagonist Norbinaltorphimine (norBNI) on Fear and Anxiety in Rats

(2012) Benjamin Rogala et al.   PLoS One

Opioid receptors: distinct roles in mood disorders

(2012) Pierre-Eric Lutz et al.   TRENDS IN NEUROSCIENCES

Kappa Opioid Receptor Signaling in the Basolateral Amygdala Regulates Conditioned Fear and Anxiety in Rats

(2011) Allison T. Knoll et al.   BIOLOGICAL PSYCHIATRY

Identification of short-acting κ-opioid receptor antagonists with anxiolytic-like activity

(2011) Matthew F. Peters et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of ATPM-ET, a novel κ agonist with partial μ activity, on physical dependence and behavior sensitization in mice

(2010) Jian-feng Sun et al.   ACTA PHARMACOLOGICA SINICA

Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala

(2010) Teresa Femenía et al.   JOURNAL OF PSYCHOPHARMACOLOGY

CRF1-R Activation of the Dynorphin/Kappa Opioid System in the Mouse Basolateral Amygdala Mediates Anxiety-Like Behavior

(2010) Michael R. Bruchas et al.   PLoS One

Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats

(2010) Gregory V. Carr et al.   PSYCHOPHARMACOLOGY

Dynorphin, stress, and depression

(2009) Allison T. Knoll et al.   BRAIN RESEARCH

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors

(2009) M.R. Bruchas et al.   BRAIN RESEARCH

Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient ofSalvia divinorum, in rodents

(2009) Daniela Braida et al.   BRITISH JOURNAL OF PHARMACOLOGY

Opiate Treatment in Depression Refractory to Antidepressants and Electroconvulsive Therapy

(2008) Peter W. Nyhuis et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Prodynorphin-Derived Peptides Are Critical Modulators of Anxiety and Regulate Neurochemistry and Corticosterone

(2008) Walter Wittmann et al.   NEUROPSYCHOPHARMACOLOGY

Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone

(2008) Ebony M. Glover et al.   PSYCHOPHARMACOLOGY

Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist

(2007) Raffaella Vergura et al.   PEPTIDES